• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白沙瓦开伯尔教学医院收治的缺血性中风患者中溶栓治疗的潜在候选情况。

Potential candidacy for thrombolysis among ischemic stroke patients presenting to Khyber Teaching Hospital, Peshawar.

作者信息

Badshah Aliena, Haider Iqbal, Atif Durkho, Taimoor Muhammad

机构信息

Aliena Badshah, Department of Medicine, MTI Khyber, Teaching Hospital Peshawar, Pakistan.

Iqbal Haider, Department of Medicine, MTI Khyber, Teaching Hospital Peshawar, Pakistan.

出版信息

Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):60-63. doi: 10.12669/pjms.40.1.7717.

DOI:10.12669/pjms.40.1.7717
PMID:38196492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10772452/
Abstract

OBJECTIVES

To determine the number of ischemic stroke patients presenting to a tertiary care hospital that are potential candidates for thrombolysis.

METHODS

This need analysis study was conducted on one hundred consecutive ischemic stroke patients during the last quarter of 2022 at the Department of Medicine, Khyber Teaching Hospital, Peshawar. The Arrival National Institute of Health Stroke Scale (NIH Stroke Scale) was calculated for all suspected stroke patients after a detailed history and clinical examination. An urgent non-contrast-enhanced CT scan brain was carried out. Patients were included in the study group after intra-cranial bleed was excluded on imaging.

RESULTS

The majority (43%) of the patients (male and female) fell in the age group 51-60 years. Fifty-nine (59%) patients had hypertension as a co-morbid condition; 49% had diabetes mellitus while the remaining percentages were constituted by other risk factors. Fifty-seven (57%) patients presented with NIH Stroke Scale between 5-15; 25% had NIH Stroke Scale greater than or equal to 21. Forty-one (41%) patients having daytime (8 am to 8 pm) strokes presented within 4.5 hours of stroke onset to the hospital while 31% of patients having nighttime strokes (8 pm to 8 am) presented within 4.5 hours of stroke onset to the hospital.

CONCLUSION

The majority (72%) of ischemic stroke patients reached the hospital facility within 4.5 hours of stroke onset. These patients can be benefited from thrombolysis leading to improved outcomes if available in that particular health facility.

摘要

目的

确定前往三级医疗医院就诊的缺血性中风患者中可能适合溶栓治疗的人数。

方法

这项需求分析研究于2022年最后一个季度在白沙瓦开伯尔教学医院内科对100例连续的缺血性中风患者进行。在详细询问病史和进行临床检查后,为所有疑似中风患者计算美国国立卫生研究院卒中量表(NIH卒中量表)。进行了紧急脑部非增强CT扫描。在影像学检查排除颅内出血后,将患者纳入研究组。

结果

大多数(43%)患者(男性和女性)年龄在51 - 60岁之间。59例(59%)患者有高血压合并症;49%患者患有糖尿病,其余百分比由其他危险因素构成。57例(57%)患者的NIH卒中量表评分为5 - 15;25%患者的NIH卒中量表评分大于或等于21。41例(41%)在白天(上午8点至晚上8点)发病的患者在发病后4.5小时内到达医院,而31%在夜间(晚上8点至上午8点)发病的患者在发病后4.5小时内到达医院。

结论

大多数(72%)缺血性中风患者在发病后4.5小时内到达医院。如果该特定医疗机构有溶栓治疗,这些患者可从中受益,从而改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dea/10772452/c10d42ba313a/PJMS-40-60-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dea/10772452/8affc03e8147/PJMS-40-60-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dea/10772452/c10d42ba313a/PJMS-40-60-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dea/10772452/8affc03e8147/PJMS-40-60-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dea/10772452/c10d42ba313a/PJMS-40-60-g002.jpg

相似文献

1
Potential candidacy for thrombolysis among ischemic stroke patients presenting to Khyber Teaching Hospital, Peshawar.白沙瓦开伯尔教学医院收治的缺血性中风患者中溶栓治疗的潜在候选情况。
Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):60-63. doi: 10.12669/pjms.40.1.7717.
2
Management of Ischemic Stroke in a Tertiary Care Hospital in Khyber Pakhtunkhwa: Existing Status and Prospective Opportunities.开伯尔-普赫图赫瓦省一家三级护理医院的缺血性中风管理:现状与潜在机遇
Cureus. 2024 Jun 25;16(6):e63094. doi: 10.7759/cureus.63094. eCollection 2024 Jun.
3
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
4
Pre- and in-hospital delays from stroke onset to intra-arterial thrombolysis.从中风发作到动脉内溶栓的院前和院内延误。
Stroke. 2003 May;34(5):1230-4. doi: 10.1161/01.STR.0000069164.91268.99. Epub 2003 Apr 17.
5
Poor recognition of prompted treatment seeking even with good knowledge of stroke warning signs contribute to delayed arrival of acute ischemic stroke patients in Thailand.即使对中风预警信号有很好的了解,患者对提示性治疗的认识不足也导致泰国急性缺血性中风患者的就诊时间延迟。
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):948-52. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.044. Epub 2013 Oct 15.
6
The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging.《洛桑急性脑卒中注册研究和分析(ASTRAL)》:一项包含急性多模态影像的缺血性脑卒中注册研究的设计和基线分析。
Stroke. 2010 Nov;41(11):2491-8. doi: 10.1161/STROKEAHA.110.596189. Epub 2010 Oct 7.
7
Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.为什么急性缺血性中风患者未接受静脉注射组织型纤溶酶原激活剂(IV tPA)?一项全国性登记研究的结果。
Neurology. 2016 Oct 11;87(15):1565-1574. doi: 10.1212/WNL.0000000000003198. Epub 2016 Sep 14.
8
Clinical outcomes of fast MRI-based trombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours.与12小时内的超急性缺血性卒中相比,基于快速磁共振成像的溶栓治疗在醒后卒中中的临床结局。
Neurol Res. 2013 Jun;35(5):492-7. doi: 10.1179/1743132813Y.0000000208. Epub 2013 Apr 19.
9
Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.3至4.5小时时间窗内急性缺血性卒中的静脉溶栓治疗——马拉巴尔地区的经验
Int J Stroke. 2014 Jun;9(4):426-8. doi: 10.1111/ijs.12128. Epub 2013 Aug 26.
10
Factors Influencing Early Hospital Arrival of Patients with Acute Ischemic Stroke, Cross-Sectional Study at Teaching Hospital in Mogadishu Somalia.影响急性缺血性中风患者早期入院的因素,索马里摩加迪沙一家教学医院的横断面研究
J Multidiscip Healthc. 2022 Dec 19;15:2891-2899. doi: 10.2147/JMDH.S392922. eCollection 2022.

本文引用的文献

1
Treatments in Ischemic Stroke: Current and Future.缺血性脑卒中的治疗:现状与未来。
Eur Neurol. 2022;85(5):349-366. doi: 10.1159/000525822. Epub 2022 Aug 2.
2
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022.世界卒中组织(WSO):全球卒中状况 2022 概要。
Int J Stroke. 2022 Jan;17(1):18-29. doi: 10.1177/17474930211065917.
3
Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review.替奈普酶与阿替普酶治疗急性缺血性卒中的系统评价
Int J Emerg Med. 2022 Jan 4;15(1):1. doi: 10.1186/s12245-021-00399-w.
4
Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke: A propensity score-matched cohort with 5-year follow-up.急性缺血性脑卒中静脉溶栓后短期和长期死亡率:5 年随访的倾向性评分匹配队列研究。
Medicine (Baltimore). 2021 Nov 5;100(44):e27652. doi: 10.1097/MD.0000000000027652.
5
Prevalence of stroke in Pakistan: Findings from Khyber Pakhtunkhwa integrated population health survey (KP-IPHS) 2016-17.巴基斯坦中风患病率:2016 - 2017年开伯尔-普赫图赫瓦省综合人口健康调查结果
Pak J Med Sci. 2020 Nov-Dec;36(7):1435-1440. doi: 10.12669/pjms.36.7.2824.
6
Cerebral Edema Associated With Large Hemispheric Infarction.与大脑半球大面积梗死相关的脑水肿
Stroke. 2019 Sep;50(9):2619-2625. doi: 10.1161/STROKEAHA.118.024766. Epub 2019 Aug 20.
7
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家卒中负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 May;18(5):439-458. doi: 10.1016/S1474-4422(19)30034-1. Epub 2019 Mar 11.
8
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.替奈普酶与阿替普酶治疗急性缺血性脑卒中的比较(NOR-TEST):一项 3 期、随机、开放标签、盲终点试验。
Lancet Neurol. 2017 Oct;16(10):781-788. doi: 10.1016/S1474-4422(17)30253-3. Epub 2017 Aug 2.
9
Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中的真实世界结局
J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1996-2003. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.010. Epub 2017 Jul 6.
10
Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults.中国脑卒中的患病率、发病率和死亡率:一项基于全国 480687 名成年人的人口普查研究结果。
Circulation. 2017 Feb 21;135(8):759-771. doi: 10.1161/CIRCULATIONAHA.116.025250. Epub 2017 Jan 4.